[Federal Register Volume 67, Number 178 (Friday, September 13, 2002)]
[Notices]
[Page 58066]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-23331]



[[Page 58066]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel, ``Partnerships for Novel 
Therapeutic, Diagnostic and Vector Control Strategies in Infectious 
Diseases'', Part II.
    Date: October 2-4, 2002.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: 5520 Wisconsin Avenue, Chevy Chase, MD 20815.
    Contact Person: Anna Ramsey-Ewing, Phd, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, NIAID, NIH, Room 2217, 6700-B Rockledge Drive, MSC 7616, 
Bethesda, MD 20892-7616, 301 496-2550, [email protected].


(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: September 5, 2002.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 02-23331 Filed 9-12-02; 8:45 am]
BILLING CODE 4140-01-M